Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Eccles

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Journal of Medical Genetics|September 1, 1995
Genotype-phenotype correlations of new causative APC gene mutations in patients with familial adenomatous polyposisD J Bunyan, J Shea-Simonds, A C Reck, et al.
Journal of Medical Genetics|June 10, 2011
Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancerD G Evans, A Howell, D Ward, et al.
Human Heredity|January 1, 1994
Prediction of genetic risks from segregation analyses of morbid risksD C Shields, A J Marlow, R S Houlston, et al.
Disease Markers|December 14, 1999
Management of hereditary breast cancer. European Familial Breast Cancer Collaborative GroupD M Eccles, P Simmonds, J Goddard, et al.
British Journal of Cancer|November 27, 2001
Minisatellite instability is found in colorectal tumours with mismatch repair deficiencyM G Coleman, A C Gough, D J Bunyan, et al.
British Journal of Cancer|January 1, 1992
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinomaD M Eccles, L Brett, A Lessells, et al.
Annals of Human Genetics|May 1, 1997
Segregation analysis of ovarian cancer using diathesis to include other cancersD M Eccles, P Forabosco, A Williams, et al.
Annals of Clinical Biochemistry|March 1, 1993
Alpha-fucosidase as a marker of genetic deletion in ovarian carcinomaG J Beattie, J E Roulston, D M Eccles, et al.
British Journal of Cancer|April 1, 1989
Cervical intraepithelial neoplasia in lymphoma patients: a cytological and colposcopic studyR G Hughes, M Colquhoun, D M Eccles, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase I and pharmacology study of GR63178A, a water-soluble analogue of mitoquidoneD M Eccles, J Cummings, M E Stewart, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Medical Genetics|September 1, 1995
Genotype-phenotype correlations of new causative APC gene mutations in patients with familial adenomatous polyposisD J Bunyan, J Shea-Simonds, A C Reck, et al.
Journal of Medical Genetics|June 10, 2011
Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancerD G Evans, A Howell, D Ward, et al.
Human Heredity|January 1, 1994
Prediction of genetic risks from segregation analyses of morbid risksD C Shields, A J Marlow, R S Houlston, et al.
Disease Markers|December 14, 1999
Management of hereditary breast cancer. European Familial Breast Cancer Collaborative GroupD M Eccles, P Simmonds, J Goddard, et al.
British Journal of Cancer|November 27, 2001
Minisatellite instability is found in colorectal tumours with mismatch repair deficiencyM G Coleman, A C Gough, D J Bunyan, et al.
British Journal of Cancer|January 1, 1992
Overexpression of the p53 protein and allele loss at 17p13 in ovarian carcinomaD M Eccles, L Brett, A Lessells, et al.
Annals of Human Genetics|May 1, 1997
Segregation analysis of ovarian cancer using diathesis to include other cancersD M Eccles, P Forabosco, A Williams, et al.
Annals of Clinical Biochemistry|March 1, 1993
Alpha-fucosidase as a marker of genetic deletion in ovarian carcinomaG J Beattie, J E Roulston, D M Eccles, et al.
British Journal of Cancer|April 1, 1989
Cervical intraepithelial neoplasia in lymphoma patients: a cytological and colposcopic studyR G Hughes, M Colquhoun, D M Eccles, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1992
A phase I and pharmacology study of GR63178A, a water-soluble analogue of mitoquidoneD M Eccles, J Cummings, M E Stewart, et al.
Pageof 6